| abstract |
The present invention relates to a neutralizing antibody of SARS-CoV-2 virus, which can bind to the S protein on SARS-CoV-2 virus, block cytopathic disease caused by SARS-CoV-2 virus or neutralize SARS-CoV-2 virus ‑CoV‑2 virus. The present invention also relates to nucleic acids encoding said antibodies or antigen-binding fragments thereof; cells containing said nucleic acids; pharmaceutical compositions containing said antibodies or antigen-binding fragments thereof, said nucleic acids, said cells; said antibodies or Its antigen-binding fragment, the nucleic acid, and the kit of the pharmaceutical composition; and the antibody or its antigen-binding fragment, the nucleic acid, and the pharmaceutical composition in the prevention, treatment, detection or diagnosis of SARS-CoV- 2 Application of virus-related diseases. |